Delivery Order SPE2DR25D2100-SPE2DR26FA0YK
- Not listed
- This is a $6,470.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The order has an ultimate completion date of August 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $3,591.50, is a firm fixed price delivery order for the pharmaceutical product MOVANTIK 25 MG TABLET 30S. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,558,975,900 units of the medication Movantik 25 mg tablets. The contract has a total ceiling value of $2,571.16 and a completion date of November 3, 2022. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This delivery order for seven hundred twenty-six dollars was awarded by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corp, located in Conshohocken, Pennsylvania, for the delivery of 4562539420 MOVANTIK 25 MG TABLET 30S. The order has a firm fixed price and completion date of October 20, 2023. No set-aside designation was used for this award placed against an existing vehicle by the Defense Logistics Agency Troop Support Medical to support its medical supply...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract has a ceiling value of $1,022.04 and a period of performance through April 15, 2024. Amerisourcebergen Drug Corp is the prime contractor, providing MOVANTIK 25 MG TABLET 30S, a specialty pharmaceutical product, to support military treatment programs and facilities. The contract does not have a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, with a ceiling value of $5,397.18, is for the delivery of MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 25, 2023. The award is not designated under any set-aside program, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,956.67 firm fixed-price delivery order is for the supply of MOVANTIK 25 MG TABLET UD 100S, a pharmaceutical product, with a completion date of January 29, 2024. The award is not associated with a set-aside program and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on June 25, 2025, valued at $2,324.64 with a firm fixed price structure. The contract calls for the delivery of Motegrity 1 mg tablets in quantities of 30, with performance to be completed at the contractor's Conshohocken facility by June 26, 2025. This delivery order was competitively awarded with no set-aside designation...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supply on August 25, 2025, with an ultimate completion date of August 26, 2025. This contract, valued at $2,857.19, covers the delivery of Motegrity 2 mg tablets (30-count units) and represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order valued at $14,920.38 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, with a firm fixed price contract type. This delivery order, issued on December 12, 2025, with an ultimate completion date of January 6, 2026, represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA. The award carries no set-aside designation, indicating it was...
- SPE2DR25D2100Indefinite Delivery Contract
- SPE2DR25D2100-SPE2DR26FA0YKDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Movantik 25 mg tablets in unit dose packaging (100 count). This contract, valued at $9,764.64 with a firm fixed price structure, was competitively awarded without set-aside designation and is scheduled for completion by January 5, 2026. The award was issued on January 2, 2026, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999 through December 2026. This comprehensive pharmaceutical support vehicle enables the company to supply a wide range of medications and medical supplies to support military healthcare systems globally. The Movantik delivery demonstrates AmerisourceBergen's role as a critical vendor for federal medical procurement, providing specialty pharmaceuticals to meet military and healthcare system requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.8k | 1/1/26 |